Cancer Models—Multiparametric Applications of Clinical MRI in Rodent Hepatic Tumor Model

Methods in Molecular Biology

Volumn 771, Issue , 2011, Pages 489-507

  Chen, Feng ^a,b   De Keyzer, Frederik ^a   Ni, Yicheng ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b SOUTHEAST UNIVERSITY   (China)

Author keywords

contrast enhanced; diffusion imaging; MRI; perfusion imaging; rodents; tumor models

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT;

ANIMAL; ARTICLE; LIVER TUMOR; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RAT;

ANIMALS; CONTRAST MEDIA; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; RATS;

ANIMALIA; RATTUS; RODENTIA;

EID: 80054730707     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-219-9_26     Document Type: Chapter

References (27)

1. Antoine E., Pauwels C., Verrelle P., Lascaux V., and Poupon M. F. (1988) In vivo emergence of a highly metastatic tumour cell line from a rat rhabdomyosarcoma after treatment with an alkylating agent. Br J Cancer 57, 469–474.
2. Hermens A. F. and Barendsen G. W. (1967) Cellular proliferation patterns in an experimental rhabdomyosarcoma in the rat. Eur J Cancer 3, 361–369.
3. Denekamp J. (1992) The choice of experimental models in cancer research: the key to ultimate success or failure? NMR Biomed 5, 234–237.
4. Thoeny H. C., De Keyzer F., Chen F., et al. (2005) Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats. Radiology 234, 756–764.
5. Kerbel R. S. (2008) Tumor angiogenesis. N Engl J Med 358, 2039–2049.
6. Chen F., Sun X., De Keyzer F., et al. (2006) Liver tumor model with implanted rhabdomyosarcoma in rats: MR imaging, microangiography, and histopathologic analysis. Radiology 239, 554–562.
7. Brockmann M. A., Kemmling A., and Gro-den C. (2007) Current issues and perspectives in small rodent magnetic resonance imaging using clinical MRI scanners. Methods 43, 79–87.
8. Inderbitzin D., Stoupis C., Sidler D., Gass M., and Candinas D. (2007) Abdominal magnetic resonance imaging in small rodents using a clinical 1.5 T MR scanner. Methods 43, 46–53.
9. Chen F., De Keyzer F., Wang H., et al. (2007) Diffusion weighted imaging in small rodents using clinical MRI scanners. Methods 43, 12–20.
10. Chen F., Suzuki Y., Nagai N., et al. (2004) Visualization of stroke with clinical MR imagers in rats: a feasibility study. Radiology 233, 905–911.
11. Chen F., Suzuki Y., Nagai N., et al. (2007) Microplasmin and tissue plasminogen activator: comparison of therapeutic effects in rat stroke model at multiparametric MR imaging. Radiology 244, 429–438.
12. Wu X., Wang H., Chen F., et al. (2009) Rat model of reperfused partial liver infarction: characterization with multiparametric magnetic resonance imaging, microangiography, and histomorphology. Acta Radiol 50, 276–287.
13. Wang H., Sun X., Chen F., et al. (2009) Treatment of rodent liver tumor with com-bretastatin A4 phosphate: noninvasive therapeutic evaluation using multiparametric magnetic resonance imaging in correlation with microangiography and histology. Invest Radiol 44, 44–53.
14. Thoeny H. C., De Keyzer F., Vandecav-eye V., et al. (2005) Effect of vascular targeting agent in rat tumor model: dynamic contrast-enhanced versus diffusion-weighted MR imaging. Radiology 237, 492–499.
15. Wang H., Van de Putte M., Chen F., et al. (2008) Murine liver implantation of radiation-induced fibrosarcoma: characterization with MR imaging, microangiography and histopathology. Eur Radiol 18, 1422–1430.
16. Carroll T. J., Rowley H. A., and Haughton V. M. (2003) Automatic calculation of the arterial input function for cerebral perfusion imaging with MR imaging. Radiology 227, 593–600.
17. Tofts P. S. (1997) Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 7, 91–101.
18. Ni Y., Wang H., Chen F., et al. (2009) Tumor models and specific contrast agents for small animal imaging in oncology. Methods 48, 125–138.
19. Le Bihan D., Breton E., Lallemand D., Aubin M. L., Vignaud J., and Laval-Jeantet M. (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168, 497–505.
20. Yamada I., Aung W., Himeno Y., Naka-gawa T., and Shibuya H. (1999) Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology 210, 617–623.
21. Sun X., Wang H., Chen F., et al. (2009) Diffusion-weighted MRI of hepatic tumor in rats: comparison between in vivo and postmortem imaging acquisitions. J Magn Reson Imaging 29, 621–628.
22. Burdette J. H., Elster A. D., and Ricci P. E. (1999) Acute cerebral infarction: quantification of spin-density and T2 shine-through phenomena on diffusion-weighted MR images. Radiology 212, 333–339.
23. Le Bihan D. (2008) Intravoxel incoherent motion perfusion MR imaging: a wake-up call. Radiology 249, 748–752.
24. Rempp K. A., Brix G., Wenz F., Becker C. R., Gückel F., and Lorenz W. J. (1994) Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 193, 637–641.
25. Weisskoff R., Boxerman J. L., Sorensen A. G., Kulke S. M., Campbell T. A., and Rosen B. R. (1994) Simultaneous blood volume and permeability mapping using a single Gd-based contrast injection. In: Proceedings of the Society for Magnetic Resonance. Berkeley, CA: Society for Magnetic Resonance, Vol. 1, p. 279.
26. Ostergaard L., Hochberg F. H., Rabinov J. D., et al. (1999) Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexametha-sone treatment in patients with brain tumors. J Neurosurg 90, 300–305.
27. Provenzale J. M., Wang G. R., Brenner T., Petrella J. R., and Sorensen A. G. (2002) Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol 178, 711–716.